Work

MEDI-573 as a novel approach to IGF-1R and IR-A signaling inhibition by blocking IGF ligands: Phase I PK/PD, safety data, and disease linkage studies in breast cancer.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.27_suppl.271

Authors: P. Haluska, J. Huang, B. Lam, M. Liang, W. Huang, P. LoRusso, M. E. Menefee, T. LaVallee, Y. Yao, J. Viner

Institutions: Mayo Clinic, The Barbara Ann Karmanos Cancer Institute, Mayo Clinic in Florida

Language: English

Topic: Growth Hormone and Insulin-like Growth Factors

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2560670204

Cites:

Cited by: 5

Related to: 10